Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | GUSB | P08236 | 2/20 | 0.33 |
| ▸ | EBP | Q15125 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.32 |
| ▸ | MGLL | Q99685 | 3/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.31 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.31 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2693560 | 1.00 | TSHR (0.38) | TSHRGUSBEBPSIGMAR1ALDH1A1 | |
| SCHEMBL4358564 | 1.00 | TSHR (0.38) | TSHRGUSBEBPSIGMAR1ALDH1A1 | |
| SCHEMBL15901603 | 1.00 | TSHR (0.38) | TSHRGUSBEBPSIGMAR1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL2900817 | 0.98 | TSHR (0.36) | TSHRGUSBEBPSIGMAR1ALDH1A1 | |
| Bromide SCHEMBL4362539 | 0.98 | TSHR (0.36) | TSHRGUSBEBPSIGMAR1ALDH1A1 | |
| Bromide SCHEMBL29249978 | 0.98 | TSHR (0.36) | TSHRGUSBEBPSIGMAR1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28380752 | 0.98 | TSHR (0.36) | TSHRGUSBEBPSIGMAR1ALDH1A1 | |
| Iodide SCHEMBL2894608 | 0.98 | TSHR (0.36) | TSHRGUSBEBPSIGMAR1ALDH1A1 | |
| SCHEMBL1680335 | 0.98 | TSHR (0.34) | TSHRGUSBEBPSIGMAR1ALDH1A1 | |
| Bromide SCHEMBL4364815 | 0.96 | TSHR (0.33) | TSHRGUSBEBPSIGMAR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1721900-B1 | NOVEL IMIDAZOLIUM COMPOUND | KANTO KAGAKU (JP) | 2014-06-11 | — | — | EP | disclosed |
| US-8084530-B2 | Sealing agent for optical semiconductor element, and optical semiconductor element | SEKISUI CHEMICAL CO., LTD. (JP) | 2011-12-27 | — | — | US | disclosed |
| US-20100171414-A1 | SEALING AGENT FOR OPTICAL SEMICONDUCTOR ELEMENT, AND OPTICAL SEMICONDUCTOR ELEMENT | SEKISUI CHEMICAL CO., LTD. (JP) | 2010-07-08 | — | — | US | disclosed |
| CN-101679613-A | Sealing agent for optical semiconductor element and optical semiconductor element | SEKISUI CHEMICAL CO LTD | 2010-03-24 | — | — | CN | disclosed |
| EP-2159242-A1 | SEALING AGENT FOR OPTICAL SEMICONDUCTOR ELEMENT, AND OPTICAL SEMICONDUCTOR ELEMENT | Sekisui Chemical Co., Ltd. (JP) | 2010-03-03 | — | — | EP | disclosed |
| US-7517999-B2 | needs no complicated operations for dissolution and has excellent handleability and a high ionic conductivity, electrolytes; 1-butyl-3-allylimidazolium bromide | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2009-04-14 | — | — | US | disclosed |
| US-20070191612-A1 | Needs no complicated operations for dissolution and has excellent handleability and a high ionic conductivity, electrolytes; 1-butyl-3-allylimidazolium bromide | HIROYUKI OHNO (JP) | 2007-08-16 | — | — | US | disclosed |
| CN-1922152-A | Novel imidazolium compound | KANTO KAGAKU (JP) | 2007-02-28 | — | — | CN | disclosed |
| EP-1721900-A1 | NOVEL IMIDAZOLIUM COMPOUND | Kanto Kagaku Kabushiki Kaisha (JP) | 2006-11-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191612-A1 | Needs no complicated operations for dissolution and has excellent handleability and a high ionic conductivity, electrolytes; 1-butyl-3-allylimidazolium bromide | SLC26A3, KCNJ11, SLC26A4 | TSHR 1992/4885GUSB 1353/4885EBP 1820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.